Diabetes mellitus is a growing global health problem that affects individuals of all ages. Anti-diabetic medications are integral for glycemic control in diabetes. Lack of adherence to drugs can alter blood glucose levels and can lead to treatment failure, accelerated development of complications, and increased morbidity, mortality, and disability. In Eritrea, adherence to anti-diabetic medication is not well studied so far. The study aimed to assess the magnitude of adherence of diabetic patients toward their anti-diabetes medication and associated factors in the diabetic clinic of Halibut National Referral Hospital. A descriptive cross-sectional study was conducted in Asmara Halibet National Referral Hospital diabetic clinic from February 01 to May 31, 2019. Subjects of the study were all diabetic patients 16 years and above and had been on diabetic treatment for not less than six months. The sample size of this study was 205 determined using Crecy & Morgan formula and convenience non-probability sampling was used to select study participants. Data were collected through an interview questionnaire assessed using self-report which then, cleaned, coded, and entered to excel and exported to SPSS for Windows version 20.0. Descriptive and inferential statistics were done to determine adherence to anti-diabetic medication and the associated factors. A total of 205 study participants were interviewed with a response rate of 100%. The level of adherence was found to be 86.3%. Factors found to be significantly associated with anti-diabetes medication were duration of diabetes (P-value=0.001), Health education about DM and its medications (P-value=0.004), taking multiple medication (P-Value=0.018), forgetfulness (P-value=0.000), and monitoring of blood glucose level (p-value=0.06). In conclusion, the majority of respondents 86.3% in this study were found to be adherent to their anti-diabetic medications. Strategies that further improves anti-diabetic drug availability, provide health education, reduce the intervals of visits for follow-ups on diabetic care, and giving explicit information and persistent close family support for those taking multiple medications may help in improving adherence levels among patients with diabetes.
展开▼
机译：糖尿病是一种不断增长的全球健康问题，影响了所有年龄段的人。抗糖尿病药物是糖尿病血糖对照的一体。缺乏对药物的粘附可以改变血糖水平，可以导致治疗失败，加速并发症的发育，发病率增加，死亡率和残疾。在厄立特里亚，到目前为止，依从抗糖尿病药物的依恋。该研究旨在评估糖尿病患者对其抗糖尿病药物治疗和糖尿病诊所的相关因素的依从性的依从性。 2019年2月01日至5月31日的Asmara Halibet国家推荐医院糖尿病诊所进行了描述性横截面研究。该研究的受试者是16岁及以上的糖尿病患者，患有糖尿病治疗不少于六个月。本研究的样本量为205，使用Crecy和摩根公式和便利性非概率抽样来选择研究参与者。通过使用自我报告评估的面试调查问卷收集数据，然后清除，编码并输入Excel并导出到SPSS for Windows 20.0。描述性和推理统计数据是为了确定抗糖尿病药物和相关因素的依从性。共有205项研究参与者接受了100％的响应率访谈。依从性的水平为86.3％。发现与抗糖尿病药物有显着相关的因素是糖尿病的持续时间（p值= 0.001），健康教育关于DM及其药物（p值= 0.004），服用多种药物（p值= 0.018），忘记（p值= 0.000），并监测血糖水平（p值= 0.06）。总之，大多数受访者在这项研究中发现了86.3％依赖于其抗糖尿病药物。进一步提高抗糖尿病药物可用性的策略，提供健康教育，减少糖尿病护理的后续行动的访问间隔，并为服用多种药物的人提供明确的信息和持续的亲密家庭支持可能有助于改善患者中的粘附水平糖尿病。
展开▼
